[go: up one dir, main page]

UY27608A1 - HYDRATED CRYSTAL FORMS OF ATORVASTATIN FORM II AND FORM IV. - Google Patents

HYDRATED CRYSTAL FORMS OF ATORVASTATIN FORM II AND FORM IV.

Info

Publication number
UY27608A1
UY27608A1 UY27608A UY27608A UY27608A1 UY 27608 A1 UY27608 A1 UY 27608A1 UY 27608 A UY27608 A UY 27608A UY 27608 A UY27608 A UY 27608A UY 27608 A1 UY27608 A1 UY 27608A1
Authority
UY
Uruguay
Prior art keywords
atorvastatin
crystal forms
hydrated crystal
heptanoic
hypercholesterolemia
Prior art date
Application number
UY27608A
Other languages
Spanish (es)
Inventor
Briggs Christopher
Jennings Rex Allen
Rpbert A Wade
Hara-Sawa Kikuko
Ichikawa Shigeru
Monohara Kazuo
Nakaguwa Shinsuke
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority to UY27608A priority Critical patent/UY27608A1/en
Publication of UY27608A1 publication Critical patent/UY27608A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen formas cristalinas de ácido (R-(R*, R*))1-2-(4-fluorofenil)-B, O-dihidroxi-5-(1-metiletil)-3-fenil-4-((fenilamino)carbonil)-1H-pirrol-1-heptanoico sal de hemi calcio, denominadas Forma II y Forma IV, caracterizadas por su difracción de polvo en rayos X y/o por su RMN de estado sólido y composiciones farmacéuticas, que sirven como agentes para tratar la hiperlipidemia e hipercolesterolemia.Crystalline forms of acid (R- (R *, R *)) 1-2- (4-fluorophenyl) -B, O-dihydroxy-5- (1-methylethyl) -3-phenyl-4 - ((phenylamino) ) carbonyl) -1H-pyrrol-1-heptanoic hemi calcium salt, called Form II and Form IV, characterized by their diffraction of X-ray powder and / or by their solid-state NMR and pharmaceutical compositions, which serve as agents for treat hyperlipidemia and hypercholesterolemia.

UY27608A 2002-12-30 2002-12-30 HYDRATED CRYSTAL FORMS OF ATORVASTATIN FORM II AND FORM IV. UY27608A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY27608A UY27608A1 (en) 2002-12-30 2002-12-30 HYDRATED CRYSTAL FORMS OF ATORVASTATIN FORM II AND FORM IV.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY27608A UY27608A1 (en) 2002-12-30 2002-12-30 HYDRATED CRYSTAL FORMS OF ATORVASTATIN FORM II AND FORM IV.

Publications (1)

Publication Number Publication Date
UY27608A1 true UY27608A1 (en) 2004-07-30

Family

ID=38812726

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27608A UY27608A1 (en) 2002-12-30 2002-12-30 HYDRATED CRYSTAL FORMS OF ATORVASTATIN FORM II AND FORM IV.

Country Status (1)

Country Link
UY (1) UY27608A1 (en)

Similar Documents

Publication Publication Date Title
AR003458A1 (en) CRYSTALLINE FORM OF ATORVASTATINE OR HYDRATE OF THE SAME AND PHARMACEUTICAL COMPOSITION THAT INCLUDES IT.
UY27359A1 (en) CRYSTAL FORMS OF THE ACID CALCIUM SALT (R- (R ', R')) - 2 (4FLUOROPHENIL) -BETA, OMEGA-DIHYDROXI-5- (1-METHYL) -3-PHENYL-4 - ((PHENYLAMINE) CARBONIL) -1H-PIRROL-1-HEPTANOIC (2: 1)
BR9610567A (en) Hemi calcium salt of (R (R *, R *) - 2- (4-fluorophenyl) -beta-delta-dihydroxy-5- (1-methyl-ethyl) -3-phenyl-4 - ((phenylamino) carbonyl ) -1H-pyrrole-1-heptanoic (atorvastatin) crystalline form iii
MXPA04000889A (en) Crystalline forms vi and vii of atorvastatin calcium.
WO2005105738A3 (en) Salt forms of atorvastatin
UY27608A1 (en) HYDRATED CRYSTAL FORMS OF ATORVASTATIN FORM II AND FORM IV.
DE602006019710D1 (en) MAGNESIUM SALT OF HMG COA REDUCTASE INHIBITORS
BRPI0414457A (en) [r- (r *, r *)] -2- (4-fluorophenyl) beta, delta-dihydroxy-5- (1-methylethyl) -3-phenyl-4 - [(phenylamino) -c acid crystalline forms arbonyl] -1h-pyrrol-1-heptanoic
TW200738624A (en) Novel forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β, δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid magnesium
WO2006011041A3 (en) Crystalline forms of (r-(r*))-2-(4-fluorophenyl)-beta, gamma-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1h-pyrrole-1-hept anoic acid calcium salt (2:1)
ECSP961823A (en) CRYSTALLINE ACID [R- (R *, R *)] - 2- (4- FLUOROFENIL) -B, 8 -DIHIDROXI- 5- (1- METHYLETHYL) - 3 - FENIL- 4- [(FENILAMINO) CARBONIL] - 1H - PIRROL - 1- HEPTANOIC CALCIUM SALT (2.1)
BRPI0511508A (en) atorvastatin salt forms, pharmaceutical composition and process
CA2521833A1 (en) Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin)
ECSP961824A (en) FORM III ACID CALCIUM SALT CRYSTALLINE [R- (R *, R *) - 2- (4 FLUOROFENIL) - B, G- DIHIDROXI-5- (1 METHYLETHYL) - 3- FENIL - 4 - [(FENILAMINO) CARBONYL] - 1H -PIRROL - 1- HEPTANOIC (2.1)
HN2002000159A (en) CRYSTAL FORMS OF THE ACID CALCIUM SALT [R- (R *, R *]] - 2- (4-FLUOROPHENIL) - B, O - DIHYDROXI - 5 - (1 - METHYL) - 3 PHENYL - 4 - (PHENYL AMINO) CARBONIL] - 1H - PIRROL - 1 - HEPTANOICP (2: 1)
IS7019A (en) Crystalline form of 'R- (R *, R *) - 2- (4-fluorophenyl) -beta, delta-dihydroxy-5- (1-methylethyl) -3-phenyl-4-phenylamino) carbonyl] -1H-carboxylic acid pyrrole-1-heptanoic acid calcium salt (2: 1) (atorvastatin)

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20170116